跳至主要内容
临床试验/IRCT2015042721970N1
IRCT2015042721970N1已完成未知

Prevalence of aspirin sensitivity in patients with moderate to severe asthma according to the response to 3 months asthma standard therapy

Vice chancellor for research, Iran Uiversity of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 18 to 65 years old; moderate to severe asthma according to the history and spirometric findings and EPR-3 (Expert Panel Report 3) guidelines
  • Exclusion criteria: Presence of serious underlying disease such as bleeding disorders, gastrointestinal, rheumatologic, cancer, heart, kidney, liver and mental diseases; medical history of immediate hypersensitivity reactions to aspirin and nonsteroidal anti-inflammatory drugs; Forced Expiratory Volume in the first second (FEV1) less than 70% at the time of aspirin challenge; pregnancy; breast-feeding; the use of systemic and topical beta-blocker, angiotensin-converting enzyme inhibitor, angiotensinogen ? receptor blocker, warfarin; mastocytosis; nonadherent patients; patients with high risk jobs or lifestyle

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Iran Uiversity of Medical Sciences

相似试验

Prevalence of aspirin sensitivity in moderate to... | 临床试验